Managed Care Plans to Help Pay Costs of Clinical Trials for Their Members

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 3
Volume 8
Issue 3

WASHINGTON-In an agreement negotiated by the National Institutes of Health and the American Association of Health Plans, the association says it will encourage its members to “reimburse the routine patient-care costs associated with NIH-sponsored clinical trials, provided those costs are not substantially higher than the costs a plan would incur in the course of standard treatment.”

WASHINGTON—In an agreement negotiated by the National Institutes of Health and the American Association of Health Plans, the association says it will encourage its members to “reimburse the routine patient-care costs associated with NIH-sponsored clinical trials, provided those costs are not substantially higher than the costs a plan would incur in the course of standard treatment.”

The agreement has been reported in The New York Times, but has not been officially announced.

Recent Videos
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content